Online inquiry

IVTScrip™ mRNA-Human ADH5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8949MR)

This product GTTS-WK8949MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADH5 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_000671.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 128
UniProt ID Q6IRT1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADH5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8949MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16204MR IVTScrip™ mRNA-Human AGMO, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AGMO
GTTS-WK6904MR IVTScrip™ mRNA-Human VASA, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA VASA
GTTS-WK23352MR IVTScrip™ mRNA-Human ATG101, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATG101
GTTS-WK2777MR IVTScrip™ mRNA-Human CD77, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA CD77
GTTS-WK8166MR IVTScrip™ mRNA-Human ABHD17A, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABHD17A
GTTS-WK11285MR IVTScrip™ mRNA-Human ADAD1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADAD1
GTTS-WK14351MR IVTScrip™ mRNA-Human ADHFE1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADHFE1
GTTS-WK10655MR IVTScrip™ mRNA-Human ACSS2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACSS2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →